Jia Ming, Hu Wen-li, Zhou Ye, Shao Juan-juan, Yan Xiao-lei, Song Tie-ying, Hou Xiao-tong, Jia Shi-jie, Meng Xu
Department of Post-operation, Intensive Care Unit of the Cardiac Surgery, Capital University of Medical Science Affiliated Beijing Anzhen Hospital, Beijing 100029, China.
Zhonghua Wai Ke Za Zhi. 2009 Sep 15;47(18):1397-9.
To investigate the treatment experience of extracorporeal membrane oxygenation (ECMO) support after cardiac surgery.
Retrospectively analyze the clinical data of 117 postoperative patients supported with ECMO in cardiac intensive care unit from March 2005 to June 2008. There were 32 female and 85 male patients, with a mean age of (48.7 +/- 16.5) years old. The cardiac operations included coronary artery bypass grafting (n = 20), coronary artery bypass grafting and remodeling of left ventricle (n = 9), coronary artery bypass grafting and valvular operation (n = 5), repair of ventricular septal perforation following acute myocardial infarction (n = 2), valvular operation (n = 46), heart transplantation (n = 20), lung heart transplantation and repair of ventricular septal defect (n = 1), correction of congenital heart defects (n = 10), aortic operations (n = 4). Venoarterial bypass was instituted in 115 for hemodynamic failure and venovenous in 2 patient for hypoxemia following cardiac surgery. ECMO was established in 110 patients by cannulation of the right atrium and femoral artery, and 5 of the right atrium and ascending aorta. And 2 case added left atrial drainage to ECMO. Heparin was infused to maintain the whole blood activated coagulation time (ACT) of 160 to 200 s in centrifugal pump (14 cases), and 200 to 250 s in roller pump (3 cases) to avoid thrombotic events. This was administered until decannulation. Intra-aortic balloon pump was used in 15 patients and continuous renal replacement therapy in 29 cases.
Mean ECMO duration was 61 h (ranged 3 to 225 h) and the mean duration of ICU stay was 5 d. 87 patients (74.4%) were successfully weaned from ECMO. 69 patients (59.0%) survived to discharge. The most common complications were re-exploration for bleeding (n = 24) and alimentary tract hemorrhage (n = 14), renal failure required renal replacement therapy (n = 29), infection(n = 32), limb ischemia (n = 5), plasma leak of oxygenators (n = 29), hemolysis (n = 7), neurological complication (n = 4).
ECMO is an effective mechanical assistance method for short-term treatment of postoperative cardiorespiratory failure. Indication should be controlled strictly. Earlier institution of ECMO and prevent complication may improve outcome.
探讨心脏手术后体外膜肺氧合(ECMO)支持的治疗经验。
回顾性分析2005年3月至2008年6月在心脏重症监护病房接受ECMO支持的117例术后患者的临床资料。其中女性32例,男性85例,平均年龄(48.7±16.5)岁。心脏手术包括冠状动脉搭桥术(n = 20)、冠状动脉搭桥术联合左心室重塑(n = 9)、冠状动脉搭桥术联合瓣膜手术(n = 5)、急性心肌梗死后室间隔穿孔修补术(n = 2)、瓣膜手术(n = 46)、心脏移植(n = 20)、心肺联合移植及室间隔缺损修补术(n = 1)、先天性心脏病矫治术(n = 10)、主动脉手术(n = 4)。115例因血流动力学衰竭行静脉 - 动脉转流,2例因心脏手术后低氧血症行静脉 - 静脉转流。110例患者通过右心房和股动脉插管建立ECMO,5例通过右心房和升主动脉插管建立。2例患者在ECMO中增加左心房引流。在离心泵(14例)中输注肝素以维持全血激活凝血时间(ACT)为160至200秒,在滚压泵(3例)中维持为200至250秒,以避免血栓形成事件。持续给药至拔管。15例患者使用主动脉内球囊泵,29例患者接受持续肾脏替代治疗。
ECMO平均持续时间为61小时(范围3至225小时),ICU平均住院时间为5天。87例患者(74.4%)成功脱离ECMO。69例患者(59.0%)存活出院。最常见的并发症是因出血再次手术(n = 24)、消化道出血(n = 14)、肾衰竭需要肾脏替代治疗(n = 29)、感染(n = 32)、肢体缺血(n = 5)、氧合器血浆渗漏(n = 29)、溶血(n = 7)、神经系统并发症(n = 4)。
ECMO是治疗术后心肺功能衰竭的一种有效的短期机械辅助方法。应严格控制适应证。早期应用ECMO并预防并发症可能改善预后。